Consistent with this hypothesis, our study provides direct evidence that Nilotinib significantly inhibited the production of phase-separated condensates of WDR3, thereby suppressing tumor growth and metastasis in vivo and in vitro (as shown in Fig. 8). Here, WDR3 is linked to neoplasm.